Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design

Clinical trial NCT01785186 · COMPLETED

Trial details

NCT number: NCT01785186
Sponsor: Michael Hoelscher
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tuberculosis, Pulmonary

Start date: 2013-04-01
Primary completion: 2014-09-01
Enrollment: 365

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.